DREW VENABLES: Open Payments
NPI 1053795997 · LEWES, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,226 in 139 payments from 17 companies in 2025. Trend: 2023 $2,724 · 2024 $3,474 · 2025 $3,226
Food & beverage: $3,119Education: $107
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $525 |
| ABBVIE INC. | 28 | $452 |
| GENZYME CORPORATION | 10 | $450 |
| UCB, Inc. | 11 | $301 |
| Novartis Pharmaceuticals Corporation | 15 | $297 |
| E.R. Squibb & Sons, L.L.C. | 9 | $214 |
| Regeneron Healthcare Solutions, Inc. | 8 | $211 |
| LEO Pharma Inc. | 13 | $198 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $106 |
| PFIZER INC. | 6 | $105 |
Products named: DUPIXENT, TREMFYA, Bimzelx, RINVOQ, Sotyktu, SKYRIZI, COSENTYX, ADBRY.
Industry payments across DE — which companies pay providers there.
